2BBBullish & Bearish
Artivion, Inc. Common Stock (AORT) trades on NYSE. It operates in the Health Care sector, Medical Devices industry. Its current 2BB score is 35 out of 100.
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
Artivion, Inc. Common Stock’s current 2BB score is 35 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 53 | Normal |
| Quality | 100 | Very Strong |
| Risk | 0 | Very Low |
| CEO | James Patrick Mackin |
| Headquarters | Kennesaw, Georgia, United States |
| Founded | 1984 |
| Employees | 1.8K |
| P/E ratio | 97.46 |
| 52-week range | $19.16 – $48.25 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-10 | — | 0.0408 | — | $130.02M |
| 2026-11-04 | — | -0.0179 | — | $123.44M |
| 2026-08-06 | — | 0.0102 | — | $122.41M |
| 2026-05-04 | — | 0.0421 | — | $118.09M |